Welltower Sees $230 Target as RBC Forecasts 17% AFFO CAGR
RBC Capital raised Welltower’s price target to $230 from $207 after the healthcare REIT reported Q4 revenue growth of 36%, EBITDA up 32% and FFO per share up 22%. The analyst projects a 17% AFFO CAGR through 2031 based on portfolio restructuring, tech investments and a strengthened balance sheet.
1. Analyst Upgrade and Price Target
RBC Capital raised Welltower’s price target to $230 from $207 and maintained an Outperform rating after stronger-than-expected Q4 results. The firm forecasts Adjusted Funds From Operations growing at a 17% compound annual rate through 2031, reflecting confidence in seniors housing demand and strategic positioning.
2. Q4 Financial Performance
In the fourth quarter, Welltower delivered 36% revenue growth, a 32% rise in EBITDA and 22% increase in FFO per share year-over-year. The company also strengthened its balance sheet by reducing leverage, marking 2025 as a financial turning point.
3. Strategic Initiatives and Growth Outlook
During the year, Welltower launched a private funds management business, updated incentive programs for employees and partners, and rolled out the Welltower Business System to improve consistency and execution. The Tech Quad initiative is expanding technology capabilities to boost operational efficiency and support long-term growth.
4. Company Portfolio Overview
Welltower’s portfolio spans over 2,000 senior housing and wellness properties across the United States, the United Kingdom and Canada. Ongoing investments in portfolio restructuring and technology position the company to capitalize on favorable demographics and industry trends.